Search clinical trials for: PF-04217329 - Vehicle

Total 2933 results

Pfizer

Completed

A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

Alzheimer's Disease

Japan
Pfizer

Completed

A Study In Healthy People To Investigate The Safety, Toleration And Time Course Of Blood Concentrations Of Multiple Doses Of PF-03654764, Given By Mouth

Healthy

Singapore
Pfizer

Completed

A Study Of Adjunctive Treatment Of Cognitive Deficits In Schizophrenia

Schizophrenia

United States
AOBiome LLC
Veristat, Inc.

Completed

Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis Eczema

United States
Dermira, Inc.

Completed

A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis

Psoriasis

Canada
Bausch & Lomb Incorporated

Completed

Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis

Conjunctivitis, Allergic

United States
Bausch & Lomb Incorporated

Completed

Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Inflammation | Cataract | Surgery

United States
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer

Keratitis | Corneal Ulcer

France
Maruho Co., Ltd.

Completed

Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis

Atopic Dermatitis

Netherlands
Maruho North America Inc.

Completed

Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis

Psoriasis

United States
Taisho Pharmaceutical R&D Inc.

Completed

Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC)

Atopic Dermatitis

United States
Pfizer

Recruiting

A Study to Learn How Different Products of the Study Medicine Called PF-07940367 Are Taken up Into the Blood in Healthy Adults

Healthy

United States
Region Örebro County
Uppsala University Hospital; Rygglkirurgiskt Centrum Stockholm AB; Norrlands...

Recruiting

Örebro Multicenter Study on Operative Treatment of Cervical Radiculopathy (OMSAP)

Cervical Radiculopathy | Cervical Root Compression

Sweden
Moorfields Eye Hospital NHS Foundation Trust
University College, London

Recruiting

A Study Of Implantation Of Retinal Pigment Epithelium In Subjects With Acute Wet Age Related Macular Degeneration

Age Related Macular Degeneration

United Kingdom
Pfizer

Completed

A Study To Evaluate The Pharmacokinetics, Excretion, Mass Balance and Metabolism of PF-07265803

Healthy

United States
Pfizer

Completed

A Study Of PF-04449913 Administered Alone In Select Solid Tumors

Solid Tumors

United States
Pfizer

Completed

PF-04634817 Renal Impairment Study

Renal Insufficiency

United States
Pfizer

Terminated

A Clinical Trial of the Study Medicine (PF-07081532) in People With Diabetes and Kidney Dysfunction

Renal Impairment | Type 2 Diabetes

United States
Telavant, Inc.
Pfizer

Completed

Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.

Colitis, Ulcerative

United States, Korea, Republic of, Belgium, Italy, Netherlands, Poland
Pfizer

Completed

Study to Evaluate Safety and Tolerability of a Single Dose of PF-06741086 in Chinese Adult Participants With Severe Hemophilia

Severe Hemophilia

China
Pfizer

Completed

A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors

NSCLC | SCCHN | Part 1 | MELANOMA | OVCA | SARCOMA | OTHER SOLID TUMORS | Part 1 and 2 | UROTHELIAL CARCINOMA

United States, Korea, Republic of, Russian Federation, Poland, Malaysia, Bulgaria, Ukraine
Pfizer

Completed

PHARMACOKINETIC CHARACTERIZATION OF PF-06651600 IN CHINESE ADULT PARTICIPANTS

Healthy Participants

China
Pfizer

Completed

Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Cancer

Head and Neck Neoplasms

Canada
Fusion Pharma LLC
Data Matrix Solutions; OCT Rus, LLC; Skolkovo Innovation Center

Unknown

Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL Gene

Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Chronic Myeloid Leukemia

Russian Federation
National Institute on Alcohol Abuse and Alcoholism...
National Center for Advancing Translational Sciences (NCATS); University of...

Completed

A Novel Compound for Alcoholism Treatment

Alcohol Drinking | Alcohol Dependence | Alcoholism | Alcohol-Related Disorders | Alcohol Drinking Related Problems

United States
Pfizer

Completed

PF-06741086 Multiple Dose Study in Severe Hemophilia

Hemophilia A or B

United States, Chile, Croatia, Poland, South Africa, Switzerland
Pfizer

Terminated

A Study Of PF-06647263 In Patients With Advanced Solid Tumors

Neoplasms | Triple-Negative Breast Cancer

United States
Pfizer

Terminated

A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors

Neoplasms | Breast Cancer

United States
Pfizer

Completed

Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors

Neoplasms

United States, Netherlands
Pfizer

Completed

A Study To Understand How The Body Reacts To A Low Dose Of PF-06427878 When Given In A Vein To Healthy, Adult, Males

Healthy

United Kingdom
Verastem, Inc.

Completed

A Study Of PF-04554878 In Patients With Advanced Non-Hematologic Malignancies (B0761001)

Cancer

United States, Canada
Pfizer

Completed

Asian Phase I Study Of PF-03446962

Neoplasms

Japan, Korea, Republic of
Pfizer

Withdrawn

A Study Of PF-03084014 In Japanese Patients With Advanced Solid Tumors

Advanced Solid Tumors
Yonsei University

Completed

PF-00299804 in Patients With Head and Neck Squamous Cell Carcinoma

Head Neck Cancer Squamous Cell Recurrent | Head Neck Cancer Squamous Cell Metastatic

Korea, Republic of
Pfizer

Completed

Study To Assess The Impact Of Hepatic Impairment On The Safety, Tolerability And Pharmacokinetics Of Single-Dose 200 Mg Of PF-868554

HEPATITIS C (HCV)

United States
Ablynx

Completed

A Single Dose Study Of The Safety And Investigational Product Level Measurement In Healthy Subjects (FIH)

Healthy

United States
Pfizer

Terminated

A Study of PF-04217903 in Patients With Advanced Cancer

Neoplasms

United States
Pfizer

Completed

A Study Of PF-03732010 In Patients With Advanced Solid Tumors

Neoplasms

Korea, Republic of, Australia, United States
Pfizer

Completed

A Clinical Study Evaluating The Safety And Tolerability Of PF-04427429 In Healthy Adult Volunteers. The Pharmacokinetics And Pharmacodynamics Of PF-04427429 Will Also Be Investigated

Healthy

Belgium
Pfizer

Completed

A Single Dose Escalation Study In Healthy Volunteers To Determine The Pharmacokinetics, Safety And Tolerability Of PF-05089771 In Healthy Volunteers

Pain

Belgium
Pfizer

Completed

A Study Of PF-00299804 In Patients In Japan With Advanced Malignant Solid Tumors

Neoplasms

Japan
Pfizer

Terminated

Single and Multiple Dose Safety, Tolerability, and Pharmacokinetics Study of PF-04805712 in Healthy Volunteers

Healthy Volunteers

Singapore
Pfizer

Completed

A Phase 1 Study To Estimate The Relative Bioavailability And Food Effect Of PF-04620110 In Healthy Adult Subjects

Healthy Volunteers

Belgium
Pfizer

Terminated

A Study To Evaluate PF-00915275 In Subjects With Type 2 Diabetes Mellitus For 4-Weeks

Diabetes Mellitus, Type 2

Belgium
Pfizer

Completed

Single Dose Study With Unlabeled Dose and 14C-labeled Microdose of PF-06700841 in Healthy Male Subjects

Healthy Male Subjects

Netherlands
Pfizer

Completed

Single Dose Lipopolysaccharide (LPS) Study In Healthy Volunteers

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Pfizer

Completed

Multiple Dose Escalation Trial Of PF-04308515 In Healthy Volunteers

Healthy

United States
Yale University
National Institute of Mental Health (NIMH); University of Pennsylvania; Columbia... and other collaborators

Recruiting

A Translational and Neurocomputational Evaluation of a Dopamine Receptor 1 Partial Agonist for Schizophrenia

Early Course Schizophrenia Spectrum Disorder

United States
Pfizer

Terminated

A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347

Healthy | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Primary Immune Thrombocytopenia

Spain, United States, Belgium, United Kingdom, New Zealand
Pfizer

Active, not recruiting

PF-07284892 in Participants With Advanced Solid Tumors

Solid Tumor

United States

3

Subscribe